Redhill Biopharma (Redhill Biopharma) Tax Rate % : 0.00% (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Redhill Biopharma Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Redhill Biopharma's Tax Expense for the three months ended in Jun. 2023 was $0.00 Mil. Redhill Biopharma's Pre-Tax Income for the three months ended in Jun. 2023 was $0.76 Mil. Therefore, Redhill Biopharma's Tax Rate % for the quarter that ended in Jun. 2023 was 0.00%.

Redhill Biopharma Tax Rate % Historical Data

The historical data trend for Redhill Biopharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Tax Rate % Chart

Redhill Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

Redhill Biopharma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

Redhill Biopharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Redhill Biopharma's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	0	/	23.952
	=	0.00 %

Redhill Biopharma's Tax Rate % for the quarter that ended in Jun. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Jun. 2023 )	/	Pre-Tax Income (Q: Jun. 2023 )
	=	0	/	0.761
	=	0.00 %

Redhill Biopharma Tax Rate % Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Redhill Biopharma (Redhill Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (NAS:RDHL) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

2RH0:Germany 2RH0:Germany

Address

21 Ha’arba’a Street, Tel Aviv, ISR, 6473921

Website

https://www.redhillbio.com

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.